NUR 6011/NUR6011 Exam 1 V1 | Advance
Pharmacology Q&A with Rationale |
William Paterson University
1. Which pharmacokinetic process is primarily affected by the first-pass effect when a drug is
administered orally?
A. Distribution
B. Absorption
C. Excretion
D. Metabolism
Answer: D
Rationale: The first-pass effect refers to the rapid hepatic metabolism of a drug before it
reaches the systemic circulation. This process significantly reduces the bioavailability of
certain oral medications. Understanding this effect is crucial for determining appropriate
dosages for oral versus parenteral routes.
2. When a drug is 95% protein-bound, which physiological change would most likely increase
the risk of toxicity?
A. Increased glomerular filtration rate
B. Hypoalbuminemia
C. High dietary intake of protein
,D. Hyperglycemia
Answer: B
Rationale: Hypoalbuminemia results in fewer binding sites for highly protein-bound
drugs, leading to an increase in the free, active fraction of the drug. This elevated level of
free drug can lead to unintended toxic effects even at standard doses. Clinicians must
monitor serum albumin levels in elderly or malnourished patients to prevent such
occurrences.
3. An agonist is defined by its ability to perform which of the following actions?
A. Block the receptor site without activation
B. Permanently damage the receptor site
C. Increase the rate of drug excretion by the kidneys
D. Bind to a receptor and trigger a biological response
Answer: D
Rationale: An agonist is a molecule that binds to a specific receptor and mimics the action
of the endogenous ligand. It possesses both affinity for the receptor and intrinsic activity to
produce a physiological effect. This is the opposite of an antagonist, which binds but does
not activate the receptor.
4. How many half-lives does it typically take for a drug to reach a steady-state concentration
in the body?
A. Four to five half-lives
, B. Ten half-lives
C. One to two half-lives
D. Seven to eight half-lives
Answer: A
Rationale: Steady state is reached when the rate of drug administration equals the rate of
drug elimination. Mathematically, it takes approximately four to five half-lives of consistent
dosing to achieve this balance. This principle helps providers predict when the full
therapeutic effect of a medication will be evident.
5. Which Cytochrome P450 enzyme is responsible for metabolizing approximately 50% of all
clinically used drugs?
A. CYP3A4
B. CYP1A2
C. CYP2D6
D. CYP2C19
Answer: A
Rationale: CYP3A4 is the most abundant and significant enzyme in the human liver for
drug metabolism. It is involved in the biotransformation of a wide variety of medications,
including statins and calcium channel blockers. Because it is so active, it is also a frequent
site for drug-drug interactions involving inhibitors and inducers.
Pharmacology Q&A with Rationale |
William Paterson University
1. Which pharmacokinetic process is primarily affected by the first-pass effect when a drug is
administered orally?
A. Distribution
B. Absorption
C. Excretion
D. Metabolism
Answer: D
Rationale: The first-pass effect refers to the rapid hepatic metabolism of a drug before it
reaches the systemic circulation. This process significantly reduces the bioavailability of
certain oral medications. Understanding this effect is crucial for determining appropriate
dosages for oral versus parenteral routes.
2. When a drug is 95% protein-bound, which physiological change would most likely increase
the risk of toxicity?
A. Increased glomerular filtration rate
B. Hypoalbuminemia
C. High dietary intake of protein
,D. Hyperglycemia
Answer: B
Rationale: Hypoalbuminemia results in fewer binding sites for highly protein-bound
drugs, leading to an increase in the free, active fraction of the drug. This elevated level of
free drug can lead to unintended toxic effects even at standard doses. Clinicians must
monitor serum albumin levels in elderly or malnourished patients to prevent such
occurrences.
3. An agonist is defined by its ability to perform which of the following actions?
A. Block the receptor site without activation
B. Permanently damage the receptor site
C. Increase the rate of drug excretion by the kidneys
D. Bind to a receptor and trigger a biological response
Answer: D
Rationale: An agonist is a molecule that binds to a specific receptor and mimics the action
of the endogenous ligand. It possesses both affinity for the receptor and intrinsic activity to
produce a physiological effect. This is the opposite of an antagonist, which binds but does
not activate the receptor.
4. How many half-lives does it typically take for a drug to reach a steady-state concentration
in the body?
A. Four to five half-lives
, B. Ten half-lives
C. One to two half-lives
D. Seven to eight half-lives
Answer: A
Rationale: Steady state is reached when the rate of drug administration equals the rate of
drug elimination. Mathematically, it takes approximately four to five half-lives of consistent
dosing to achieve this balance. This principle helps providers predict when the full
therapeutic effect of a medication will be evident.
5. Which Cytochrome P450 enzyme is responsible for metabolizing approximately 50% of all
clinically used drugs?
A. CYP3A4
B. CYP1A2
C. CYP2D6
D. CYP2C19
Answer: A
Rationale: CYP3A4 is the most abundant and significant enzyme in the human liver for
drug metabolism. It is involved in the biotransformation of a wide variety of medications,
including statins and calcium channel blockers. Because it is so active, it is also a frequent
site for drug-drug interactions involving inhibitors and inducers.
